Head of Russia’s sovereign wealth fund volunteers to test experimental Covid-19 vaccine on himself
Speaking to Moscow business daily RBK, Dmitriev explained that he took part in the volunteer program, and so far, things seem to be going well.
“Well, for now, you see, everything is fine. I will keep you posted. A vaccine is, of course, the most important element, but not the only one – it is important to have testing and drugs for treatment,” he said.Also on rt.com Light at the end of the tunnel? Russian scientists test potential Covid-19 vaccine on 18 volunteers
The Ministry of Health approved the testing of the Russian Covid-19 vaccine on humans on June 16, and the first volunteers were vaccinated on June 18. Produced by Moscow’s Gamaleya Institute of Epidemiology and Microbiology, the injection is being trialed under the supervision of the Ministry of Defense. The experiment is due to be completed by next month. Thus far, no volunteers have reported side effects.
According to Dmitriev, Russia will begin producing the vaccine in September, even before the drug is officially registered, in order to stockpile. Initially, the vaccine will only be distributed in Russia, but there will be an opportunity to aid other nations as the country’s population is vaccinated, he said.Also on rt.com Back in business? Moscow economy almost back to normal as capital lifts lockdown
Dmitriev, as the head of Russia’s sovereign wealth fund, is responsible for over $171 billion worth of assets.
Like this story? Share it with a friend!